ClinicalTrials.gg
Enrolling by invitationNCT06447922Updated Nov 19, 2026

Metal Ion Concentrations After Total Knee Arthroplasty

An observational study in Arthroplasty, Replacement, Knee, Total Knee Replacement and Blood Metal Ion Concentration, sponsored by Mayo Clinic. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Mayo Clinic · Observational

How we know

Updated Nov 19, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The purpose of this study is to analyze the metal ion concentrations in the patients blood following robotic-assisted total knee arthroplasty (TKA) compared to conventional total knee arthroplasty using cutting guides.

Read the detailed description

This study focuses on comparing metal ion levels in 50 inpatient participants undergoing primary total knee arthroplasty (TKA) with either conventional cutting guides or robotic assistance. Baseline blood examinations for Cobalt, Chromium, Titanium, and Nickel will be performed before TKA implantation at preoperative visits and on the first day following the procedure. The investigation will encompass patients receiving both conventional and robotic-assisted primary TKA, framed within a prospective cohort study design. Baseline characteristics and additional follow-up information will be gathered.

02

Conditions studied

  • Arthroplasty, Replacement, Knee
  • Total Knee Replacement
  • Blood Metal Ion Concentration
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,272 studies on the registry; 672 are open to participants now.

Of its 452 completed or terminated interventional studies of FDA-regulated products, 322 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adult patients eligible for a primary total knee replacement who have not had a prior joint replacement or surgery where metal implants were placed.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults undergoing conventional or robotic-assisted TKA
  • Consent to the study

Exclusion criteria

Exclusion Criteria:

  • Patients who have undergone any previous arthroplasty procedures.
  • Patients with metal implants, such as plates, nails, and screws, used in the repair of traumatic injuries.
  • Patients below 110 pounds.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Conventional TKA with Cutting Guides

    Patients undergoing a conventional total knee arthroplasty with cutting guides (no robot-assistance).

    Other: Metal ion level testing

  • Robot-Assisted TKA

    Patients undergoing a robot-assisted total knee arthroplasty.

    Other: Metal ion level testing

Interventions

  • OtherMetal ion level testing

    Patients will undergo a pre- and post-operative blood draw to analyze metal ion levels (Cobalt, Chromium, Titanium and Nickel)

06

What researchers measure

Primary outcomes

  1. Overall blood metal ion differences between procedures (Conventional TKA vs Robot-Assisted TKA)

    Difference in overall blood metal ion levels (Cobalt, Chromium, Titanium, and Nickel) between patients undergoing total knee arthroplasty (TKA) with conventional cutting guides and those undergoing TKA with robotic assistance.

    Time frame: Pre-operatively, first post-operative day.

Secondary outcomes

  1. Comparison of post-operative blood metal levels between procedures: Cobalt

    Difference in post-operative levels, adjusted for the pre-operative levels, between Conventional TKA with Cutting Guides vs Robot-Assisted TKA

    Time frame: First post-operative day

  2. Comparison of post-operative blood metal levels between procedures: Chromium

    Difference in post-operative levels, adjusted for the pre-operative levels, between Conventional TKA with Cutting Guides vs Robot-Assisted TKA

    Time frame: First post-operative day

  3. Comparison of post-operative blood metal levels between procedures: Titanium

    Difference in post-operative levels, adjusted for the pre-operative levels, between Conventional TKA with Cutting Guides vs Robot-Assisted TKA

    Time frame: First post-operative day

  4. Comparison of post-operative blood metal levels between procedures: Nickel

    Difference in post-operative levels, adjusted for the pre-operative levels, between Conventional TKA with Cutting Guides vs Robot-Assisted TKA

    Time frame: First post-operative day

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2024 (actual). Primary completion is estimated for Oct 2027, 40 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Oct 2026 → Oct 2027 and completion Oct 2026 → Oct 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2024
First posted
Jun 7, 2024
StartActual
Jun 25, 2024
Primary completionEst.
Oct 2027was Oct 2026
CompletionEst.
Oct 2027was Oct 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 2026→Oct 2027
Nov 19, 2026
Study completion
Oct 2026→Oct 2027
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Primary completion Oct 2026→Oct 2027
    Study completion Oct 2026→Oct 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06447922
Lead sponsor
Mayo Clinic
Responsible party
Matthew P. Abdel, M.D. (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Jun 7, 2024
Start date
Jun 25, 2024
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Matthew P Abdel
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion